熔点	33-36 ºC
沸点	216 ºC
闪点	102 ºC

危险品标志	Xi
危险类别码	R36/37/38
安全说明书	S26;S36

来源	SDS样本
Alfa-Aesar	浏览或下载
Sigma-Aldrich	浏览或下载
TCI	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.Qian Jiang et al.Journal of gastroenterology and hepatology, 24(1), 9-14 (2008-10-01) Modulation of neural activation following treatment of hepatic encephalopathy.Mark J W McPhail et al.Neurology, 80(11), 1041-1047 (2013-02-22) Treatment of hyperammonemia in liver failure: a tale of two enzymes.Rajiv Jalan et al.Gastroenterology, 136(7), 2048-2051 (2009-05-05) Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy.Suzanna Ndraha et al.Acta medica Indonesiana, 42(3), 158-161 (2010-08-21) [Hepatic dysfunction correction in patients with obturation jaundice].B M Datsenko et al.Klinichna khirurhiia, (4)(4), 9-12 (2013-07-31) The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.Suzanna Ndraha et al.Acta medica Indonesiana, 43(1), 18-22 (2011-02-23) L-Aspartate, L-Ornithine and L-Ornithine-L-Aspartate (LOLA) and Their Impact on Brain Energy Metabolism.Abhijit Das et al.Neurochemical research, 45(6), 1438-1450 (2020-05-20) [Fulminate liver failure in a 39-year-old female patient with leukocytosis, unclear fever, and arthralgic pain].Babette Linde et al.Medizinische Klinik (Munich, Germany : 1983), 102(10), 846-851 (2007-10-12) Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.Gavin Wright et al.Liver international : official journal of the International Association for the Study of the Liver, 31(2), 163-175 (2010-08-03) Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.Jorge Luis Poo et al.Annals of hepatology, 5(4), 281-288 (2006-12-08) Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS.M Bai et al.Alimentary pharmacology & therapeutics, 40(1), 63-71 (2014-05-17) A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.Patrícia Coelho de Soárez et al.Arquivos de gastroenterologia, 46(3), 241-247 (2009-11-18) Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.Janus P Ong et al.Clinical drug investigation, 31(4), 213-220 (2011-01-07) Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.Subrat Kumar Acharya et al.Gastroenterology, 136(7), 2159-2168 (2009-06-10) A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy.Vibhu Vibhas Mittal et al.European journal of gastroenterology & hepatology, 23(8), 725-732 (2011-06-08) The treatment of hepatic encephalopathy.Marsha Y Morgan et al.Metabolic brain disease, 22(3-4), 389-405 (2007-09-12) Metabolic engineering of Corynebacterium glutamicum S9114 to enhance the production of l-ornithine driven by glucose and xylose.Bin Zhang et al.Bioresource technology, 284, 204-213 (2019-04-03) A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.Monika Schmid et al.Liver international : official journal of the International Association for the Study of the Liver, 30(4), 574-582 (2010-05-12) [Study on L-Ornithine-L-Aspartate in the treatment of acute-on-chronic liver failure].Cui-ping Liu et al.Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 19(1), 63-64 (2011-01-29) [Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver].Abdol A Ameri MMW Fortschritte der Medizin, 152(22), 42-43 (2010-07-02) [New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases].S Iu Ermolov et al.Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, (4)(4), 82-87 (2008-04-16) L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.Irfan Ahmad et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 18(11), 684-687 (2008-11-06) Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model.Takeyori Saheki et al.Scientific reports, 9(1), 4179-4179 (2019-03-14) Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction.Vanessa Stadlbauer et al.Metabolic brain disease, 22(1), 45-50 (2006-12-14) Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.Claudia Isabel Blanco Vela et al.Annals of hepatology, 10 Suppl 2, S55-S59 (2012-01-18) [Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver].A G Evdokimova et al.Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 56(5-6), 64-68 (2011-12-08) Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy.Shahab Abid et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 21(11), 666-671 (2011-11-15) [Hepatic encephalopathy and liver transplantation].Imre Fehérvári et al.Magyar sebeszet, 65(2), 58-62 (2012-04-20) Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure.José Luis Pérez Hernández et al.Annals of hepatology, 10 Suppl 2, S66-S69 (2012-01-18)

备注